Free Trial

CARGO Therapeutics (CRGX) Competitors

CARGO Therapeutics logo
$4.52 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$4.52 0.00 (0.00%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CRGX vs. TRVI, CMRX, CRON, QURE, OCS, ANAB, BGM, CRMD, VIR, and KALV

Should you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Trevi Therapeutics (TRVI), Chimerix (CMRX), Cronos Group (CRON), uniQure (QURE), Oculis (OCS), AnaptysBio (ANAB), BGM Group (BGM), CorMedix (CRMD), Vir Biotechnology (VIR), and KalVista Pharmaceuticals (KALV). These companies are all part of the "pharmaceutical products" industry.

CARGO Therapeutics vs. Its Competitors

Trevi Therapeutics (NASDAQ:TRVI) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

In the previous week, CARGO Therapeutics had 2 more articles in the media than Trevi Therapeutics. MarketBeat recorded 4 mentions for CARGO Therapeutics and 2 mentions for Trevi Therapeutics. Trevi Therapeutics' average media sentiment score of 1.04 beat CARGO Therapeutics' score of 0.93 indicating that Trevi Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Trevi Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CARGO Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Trevi Therapeutics has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500.

95.8% of Trevi Therapeutics shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 18.3% of Trevi Therapeutics shares are held by company insiders. Comparatively, 2.9% of CARGO Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Trevi Therapeutics is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trevi TherapeuticsN/AN/A-$47.91M-$0.45-17.49
CARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.98

CARGO Therapeutics' return on equity of -45.93% beat Trevi Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Trevi TherapeuticsN/A -58.41% -52.52%
CARGO Therapeutics N/A -45.93%-39.58%

Trevi Therapeutics currently has a consensus target price of $20.88, indicating a potential upside of 165.25%. CARGO Therapeutics has a consensus target price of $15.40, indicating a potential upside of 240.71%. Given CARGO Therapeutics' higher probable upside, analysts plainly believe CARGO Therapeutics is more favorable than Trevi Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trevi Therapeutics
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
3 Strong Buy rating(s)
3.30
CARGO Therapeutics
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86

Summary

Trevi Therapeutics beats CARGO Therapeutics on 9 of the 14 factors compared between the two stocks.

Get CARGO Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRGX vs. The Competition

MetricCARGO TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$208.42M$3.04B$5.74B$9.51B
Dividend YieldN/A2.40%4.60%3.99%
P/E Ratio-0.9821.1828.1120.03
Price / SalesN/A339.43461.37103.88
Price / CashN/A43.2336.5559.01
Price / Book0.588.368.655.90
Net Income-$167.50M-$55.19M$3.25B$258.66M
7 Day Performance-1.09%5.89%4.20%2.23%
1 Month Performance9.18%17.63%10.82%12.76%
1 Year Performance-74.46%5.09%34.70%19.36%

CARGO Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRGX
CARGO Therapeutics
2.0634 of 5 stars
$4.52
flat
$15.40
+240.7%
-73.9%$208.42MN/A-0.98116
TRVI
Trevi Therapeutics
3.8764 of 5 stars
$7.01
+7.0%
$20.88
+197.8%
+164.0%$822.20MN/A-15.5820Positive News
CMRX
Chimerix
0.7411 of 5 stars
$8.54
flat
$8.53
-0.1%
N/A$801.09M$212K-9.0990
CRON
Cronos Group
2.0405 of 5 stars
$2.07
-1.0%
N/A-12.7%$798.36M$117.61M15.92450News Coverage
QURE
uniQure
2.3882 of 5 stars
$14.55
+1.0%
$37.82
+159.9%
+88.2%$797.05M$27.12M-3.31500
OCS
Oculis
2.2535 of 5 stars
$18.16
+0.6%
$35.33
+94.6%
+51.0%$792.90MN/A-6.882
ANAB
AnaptysBio
1.7555 of 5 stars
$26.95
+2.9%
$42.38
+57.2%
-26.9%$791.79M$91.28M-5.56100News Coverage
Positive News
Analyst Forecast
BGM
BGM Group
N/A$8.08
-13.2%
N/AN/A$785.54M$25.10M0.00298
CRMD
CorMedix
2.794 of 5 stars
$11.36
+1.2%
$17.14
+50.9%
+141.1%$770.49M$82.55M51.6430Positive News
VIR
Vir Biotechnology
3.6999 of 5 stars
$5.50
-2.7%
$30.25
+450.0%
-43.0%$760.32M$74.21M-1.30580
KALV
KalVista Pharmaceuticals
4.1141 of 5 stars
$15.22
+4.8%
$26.29
+72.7%
+7.8%$760.24MN/A-4.12100High Trading Volume

Related Companies and Tools


This page (NASDAQ:CRGX) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners